Albany Molecular Research...

NASDAQ: AMRI · Real-Time Price · USD
21.74
0.00 (0.00%)
At close: Jun 29, 2019, 12:07 AM

Albany Molecular Research Revenue Breakdown

Period Ending Dec 31, 2016 Dec 31, 2015 Dec 31, 2013 Dec 31, 2012
Active Pharmaceutical Ingredients Revenue 9.39M 12.08M 105.03M 105.5M
Active Pharmaceutical Ingredients Revenue Growth -22.24% -88.50% -0.44% n/a
Corporate Segment Revenue n/a n/a n/a n/a
Corporate Segment Revenue Growth n/a n/a n/a n/a
Discovery Drug Development And Small Scale Manufacturing Revenue n/a 5.54M n/a n/a
Discovery Drug Development And Small Scale Manufacturing Revenue Growth -100.00% n/a n/a n/a
Drug Product Manufacturing Revenue 629K n/a n/a n/a
Drug Product Manufacturing Revenue Growth n/a n/a n/a n/a
Fine Chemicals Revenue n/a n/a n/a n/a
Fine Chemicals Revenue Growth n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 38.65M 33.43M 32.31M 37.3M 27.93M 24.6M 22.18M 21.22M 16.52M 17.47M
Selling, General, and Administrative Revenue Growth +15.60% +3.47% -13.39% +33.58% +13.52% +10.90% +4.54% +28.46% -5.47% n/a
Research and Development Revenue 3.46M 3.37M 4.76M 4.64M 3.48M 3.17M 2.7M 1.9M 385K 490K
Research and Development Revenue Growth +2.61% -29.07% +2.48% +33.43% +9.82% +17.51% +41.67% +394.29% -21.43% n/a